ADCT vs AAPL · rev $40.1M vs P/E 39, rev $416.16B
ADC Therapeutics SA (ADCT) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
ADCT currently screens at market cap $141.2M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the ADCT and AAPL stock pages for the full models.
Not investment advice.